BRAMPTON, Ontario--(BUSINESS WIRE)--Taro Pharmaceuticals Inc. has initiated a voluntary Type 1 recall to the patient level on six (6) lots of Taro-Zoledronic Acid Injection, 5 mg/100 mL in 100 mL vials. The reason for the recall is that product from these
MISSISSAUGA, Ontario--(BUSINESS WIRE)--$MDX #SkinCancer--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that, in connection with the Private Placement (the “Financing”), the
The Funding Will Support New Research Initiatives Around Brain Health and Increasing Accessibility to The Company’s EEG Technology Platform TORONTO--(BUSINESS WIRE)--Interaxon Inc. ( Muse®), the leading consumer neurotechnology company, announced that
Investment in Response to Increased Demand for North American-Based Chemistry Services OAKVILLE, Ontario--(BUSINESS WIRE)--GL CHEMTEC (“GLC”), a specialist in advanced chemistry R&D and scale-up services to support Active Pharmaceutical Ingredien
Patient recruitment in the Phase 2B VITALIZE DLBCL trial of MVP-S plus Keytruda continues to track well, with first results expected in Q3 2022. Matthew J. Matasar, MD from Memorial Sloan Kettering Cancer Center, has joined VITALIZE as lead principal inv
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) today announced its financial results for the three- and six-month periods ended June 30, 20221. Three-months en
- Completed positive End-of-Phase 2 meeting with the Food and Drug Administration (“FDA”) and received scientific advice from the European Medicines Agency (“EMA”) to support design of its CALM Phase 3 program, which is expected to initiate in Q4
Revenue increased 20.4% vs. prior year to $243.5 million Gross profit increased $8.6 million to $34.9 million and gross margin expanded 130 basis points to 14.3% Net earnings from continuing operations of $2.5 million compared to a net loss of $0.9 mil
-- Transformational precision gene delivery company launched out of Versant’s Ridgeline Discovery Engine – -- Vector developing platform for precisely targeted delivery of high-capacity genetic payloads -- BASEL, Switzerland--(BUSINESS WIRE)--Versan
FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its first half 2022 ea
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.